Iboga and Neuroplasticity: What the Science Says About the Brain's Window for Change
Updated: 3 days ago

For over a decade, one question has come up more than almost any other in my conversations with people considering ceremony:
"Is it true that iboga actually changes the brain?"
People have heard words like neuroplasticity, neurogenesis, "rewiring." Some have heard Joe Dispenza talk about how neurons that fire together, wire together, and that we can break the habit of being ourselves. Others have read the headlines about veterans and brain injuries.
So let's talk about it honestly: what the research actually shows, what it doesn't show yet, and how I understand it from the ceremonial side.
First, what is neuroplasticity?
Neuroplasticity is the brain's ability to change. To form new connections, strengthen some pathways and let others fade.
When we're young, the brain is extremely open. Children learn languages, social rules and ways of seeing the world almost effortlessly. Scientists call these windows "critical periods." As we get older, those windows close. The brain becomes more efficient, but also more fixed. We get stuck in the same thoughts, the same reactions, the same stories about who we are.
Most people who reach out to me aren't looking for a "drug experience." They're looking for a way out of a loop they've been in for years.
What the research shows
1. The Stanford veterans study (2024)
In January 2024, researchers at Stanford published a study in Nature Medicine following 30 US Special Operations veterans with traumatic brain injuries from combat and blast exposure. They travelled to a medically supervised clinic in Mexico and received ibogaine together with magnesium, which was used to help protect the heart.
The results were striking. Before treatment, the group's average disability score was in the mild-to-moderate range. One month later, the average score indicated no disability, and the researchers also reported improvements in PTSD, depression, anxiety, concentration and memory. The lead researcher, Dr. Nolan Williams, said no other drug has been able to broadly relieve these symptoms the way they observed with ibogaine.
It's important to be honest about what this study is and isn't:
It was small (30 people) and not a randomized controlled trial.
Participants also received other support, including coaching and group work, so it's not possible to separate the effect of ibogaine alone.
Participants were carefully screened, and treatment happened under medical monitoring.
It's a powerful early signal, not a final answer.
2. Reopening the "critical period" (Johns Hopkins, 2023)
In 2023, neuroscientist Dr. Gül Dölen and her team at Johns Hopkins published research in Nature showing that several psychedelics, including ibogaine, could reopen a "critical period" for social learning in adult mice. That's a window of heightened openness normally only seen in youth.
What fascinated me most was this: the length of time the window stayed open seemed to follow the length of the experience itself. In the mice, ketamine kept it open for about 48 hours, psilocybin about two weeks, LSD about three weeks, and ibogaine about four weeks, the longest of all the substances tested.
Dr. Dölen described this open state as a possible opportunity for integration after treatment. It may be a time when new learning can take root, rather than people rushing straight back into their old, busy lives.
This was research in mice, and we don't yet know exactly how it translates to humans. But it gives language to something I've watched for years.
3. Growth factors in the brain
Animal studies have also found that ibogaine can increase the expression of neurotrophic factors such as GDNF and BDNF. These are proteins that support the growth, repair and survival of brain cells. Much of this research has focused on why ibogaine appears to reduce drug-seeking behaviour. Again, this is early-stage science, mostly in animals, and more research is needed.
The ceremonial side: truth changes the brain too
Here's where science and spirit meet for me.
Neuroplasticity explains that the brain can change. But the question is: change toward what?
In ceremony, people often see their lives with a clarity they haven't had in years. Old beliefs ("I'm not enough," "I can't change," "this is just who I am") get looked at directly, sometimes for the first time. When we bring truth to something we've been carrying, we start to relate to it differently.
From a neuroscience view, that's new learning during a window of openness. From a spiritual view, it's remembering who we are underneath the patterns.
I don't think those are two different things. I think they're two languages describing the same doorway.
Why the weeks after matter most
If there really is a window, then what you do inside it matters.
That's why our retreats don't end when ceremony ends. Preparation before, and integration after: new habits, honest conversations, rest, nature, community, and support while the brain and heart are most open. This is where real, lasting change is built.
A window that opens and then fills with the same old routines simply closes again.
A note on safety
Iboga and ibogaine are powerful and are not right for everyone. They carry real risks, including serious heart risks, and can interact dangerously with certain medications and conditions. This is why every person who comes to us goes through careful screening before they're accepted, and why support continues before, during and after ceremony.
This article is for education only. It is not medical advice and makes no promise of any specific outcome. Please speak with your doctor about your own health.
Want to learn more?
If you've been feeling stuck in the same patterns and want to understand what a retreat with us actually looks like, I've made a short video that walks you through it: how we prepare, what the days look like, how we keep people safe, and the support afterwards.
With respect, Mark Howard IbogaSoul
Sources
Cherian, K.N., et al. (2024). Magnesium–ibogaine therapy in veterans with traumatic brain injuries. Nature Medicine. doi.org/10.1038/s41591-023-02705-w
Nardou, R., et al. (2023). Psychedelics reopen the social reward learning critical period. Nature, 618, 790–798. doi.org/10.1038/s41586-023-06204-3
Marton, S., et al. (2019). Ibogaine Administration Modifies GDNF and BDNF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits. Frontiers in Pharmacology, 10:193.

Comments